Foundation Medicine

Combines tumor DNA sequencing and liquid biopsy to uncover targetable variants and treatment-guiding biomarkers.

Vetted listingTakes insuranceFinancial aid availableFeatured

DiagnosticsTestingTreatment Options6 offerings

Consented intake · your records travel with you · nothing moves without your sign-off

Why Foundation exists

Foundation Medicine offers DNA sequencing of tumor tissue to map the variants driving a patient's cancer, especially those that can be targeted for treatment, along with liquid biopsy analysis of blood for treatment-guiding biomarkers. For patients, this pairs a deep genetic profile of the tumor with a blood-based view that can help monitor the disease.

FDA approved companion diagnostics · FoundationOne CDx and FoundationOne Liquid CDxCompanion diagnostic indications · 100 approved indications for next generation sequencingClinical trial experience · Supported more than 950 clinical trials

1
Care team orders a biomarker test
The patient's care team selects and orders a Foundation Medicine biomarker test.
2
Sample goes to the lab
The tissue or blood sample is sent to the Foundation Medicine laboratory for analysis.
3
Results are shared with the care team
After the sample is analyzed, results are delivered to the care team. Most patients do not need to do anything during the process.
4
Discuss treatment options
The patient and care team review the results together and discuss treatment options.

Prefer the source? Foundation Medicine's own site has more.

Share your records

We'll pre-fill the intake from your records — no retyping.

Start sharing →

Check your coverage

See if your insurance covers this and estimate out-of-pocket cost.

Check coverage →

What they offer

Diagnostics· 2

FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
FoundationOne Liquid CDx is a blood-based comprehensive genomic profiling test when tissue is unavailable or insufficient.

Testing· 2

Gather distinctive biomarkers that can guide treatment and monitor disease progression
Uncover what genetic coding is driving my cancer, especially those variants of interest that can be targeted for treatment

Treatment Options· 2

Identify the best treatment ideas using the best global thinking, predict treatment response, assess confidence in outcome
Identify the best treatment ideas using the best global thinking, predict best treatment response

Coverage, insurance & cost

The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Foundation Medicine handles billing.

Insurance

Accepted

Financial aid

Available

In-network carriers

MedicareAetnaBlue Cross Blue ShieldCignaHumanaUnitedHealthcare

Build a personalized cost estimate

Common questions about Foundation

Does Foundation take insurance?

Foundation accepts insurance; In-network carriers include Medicare, Aetna, Blue Cross Blue Shield, Cigna, Humana; financial assistance is available. Add your plan on OpenCancer to check coverage before you commit.

How does Foundation work?

1. Care team orders a biomarker test — The patient's care team selects and orders a Foundation Medicine biomarker test. 2. Sample goes to the lab — The tissue or blood sample is sent to the Foundation Medicine laboratory for analysis. 3. Results are shared with the care team — After the sample is analyzed, results are delivered to the care team. Most patients do not need to do anything during the process. 4. Discuss treatment options — The patient and care team review the results together and discuss treatment options.

How do I connect with Foundation?

Through OpenCancer's consented intake: enter your details once, choose exactly which records travel with the request, and sign a consent that covers this connection only. Nothing is shared without your sign-off.